Corrigendum to \"International expert consensus on the clinical integration of circulating tumor cells in solid tumors\" [Eur. J. Cancer 231 (2025) 116050].
AuteursNicolò E, Reduzzi C, Pierga JY, Gazzaniga P, Stoecklein NH, Denninghoff V, Rothwell DG, De Bono JS, Marchetti D, Lianidou E, Riethdorf S, Generali D, Hofman P, Gerratana L, Kuhn P, Thiery JP, Ignatiadis M, Bidard FC, Lucci A, Kasimir-Bauer S, Serrano MJ, Cristofanilli M
Reply to Satapathy et al.'s comment on \"Dual cross-sectional and longitudinal perspective on the continuum of HIV care to disentangle natural epidemic evolution from real progress, Belgium 2014-2022\".
AuteursVan Beckhoven D, Serrien B, Demeester R, Van Praet J, Messiaen P, Darcis G, Henrard S, De Munter P, Libois A, Deblonde J
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer: Updated Efficacy Results from the phase 3 EMBER-3 trial.
AuteursJhaveri KL, Neven P, Casalnuovo ML, Kim SB, Tokunaga E, Aftimos P, Saura C, O'Shaughnessy J, Harbeck N, Carey LA, Curigliano G, Watanabe J, Lim E, Huang J, Qingyuan Z, Llombart-Cussac A, Huang C, Desai B, Limay Y, Wang XA, Cao S, Bidard FC
Personalized ctDNA detection and genomic profiling in the NeoRHEA Study.
AuteursStanciu A, Agostinetto E, Papagiannis A, Pipinikas C, Chevalier A, Campbell N, Brandão M, Ameye L, Paesmans M, Besse T, Rothe F, Buisseret L, Taylor D, Neven P, Sotiriou C, Duhoux FP, Vuylsteke P, Ignatiadis M